The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant chemotherapy and radiation therapy (RT) versus RT alone for women with high-risk endometrial cancer: Toxicity and quality-of-life results of the randomized PORTEC-3 trial.
 
Carien L. Creutzberg
No Relationships to Disclose
 
Stephanie M. de Boer
No Relationships to Disclose
 
Hein Putter
No Relationships to Disclose
 
Melanie Powell
No Relationships to Disclose
 
Linda R. Mileshkin
No Relationships to Disclose
 
Dionyssios Katsaros
No Relationships to Disclose
 
Paul Bessette
Honoraria - Merck
Consulting or Advisory Role - Merck
 
Christine Haie-Meder
No Relationships to Disclose
 
Jonathan A. Ledermann
Research Funding - AstraZeneca (Inst)
 
P. B. Ottevanger
Consulting or Advisory Role - MSD (Inst)
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - Novartis
 
Pearly Khaw
No Relationships to Disclose
 
Alessandro Colombo
No Relationships to Disclose
 
Anthony W. Fyles
No Relationships to Disclose
 
Marie-Helene Baron
No Relationships to Disclose
 
Hans W. Nijman
Stock and Other Ownership Interests - ViciniVax
Research Funding - Bionovion
 
Remi A. Nout
No Relationships to Disclose
 
Vincent T.H.B.M. Smit
No Relationships to Disclose
 
Karen Verhoeven-Adema
No Relationships to Disclose
 
Roy F.P.M. Kruitwagen
No Relationships to Disclose
 
Henry C. Kitchener
Research Funding - Genticel (Inst); GlaxoSmithKline (Inst)